Targeting PIK3CG in Combination with Paclitaxel as a Potential Therapeutic Regimen in Claudin-Low Breast Cancer [Corrigendum]

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Corrigendum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7234805/
https://www.ncbi.nlm.nih.gov/pubmed/32494196
http://dx.doi.org/10.2147/CMAR.S260280

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7234805/
https://www.ncbi.nlm.nih.gov/pubmed/32494196
http://dx.doi.org/10.2147/CMAR.S260280

Ejemplares similares